Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4nka | 2K7 | Fibroblast growth factor receptor 1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 1.000 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.508 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.506 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.506 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.499 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.494 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.490 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.488 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.482 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.479 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.477 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.477 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.475 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.469 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.466 | |
3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.465 | |
3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.463 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.459 | |
3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.457 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.451 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.451 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.449 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.447 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.445 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.443 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.443 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.441 |